HRW Criticises Proposed Abortion Pill Rules in South Korea
Seoul, Oct 27: Human Rights Watch (HRW) has questioned draft regulations that would allow abortion pills to be formally used in South Korea from next year. The group argued that tight restrictions could weaken women’s and girls’ access to safe and affordable reproductive healthcare.
While HRW welcomed the move to approve abortion medications, it said the rules being prepared should not create unnecessary obstacles. The New York-based group noted that the proposed system could end years of regulatory uncertainty, provided the framework is adjusted.
HRW issued a statement on Sunday calling on the South Korean government to guarantee wide access to abortion drugs. Its acting women’s rights research assistant, Suzanne Burgstein, said approving the pills was important. She stressed that the government must avoid rules so strict that women lose their right to abortion or face high costs.
The South Korean government announced in September that it plans to formally permit abortion medications up to nine weeks of pregnancy. Under the plan, doctors at major medical institutions alone would be able to prescribe and directly dispense the drugs during the first two years. Changes to the system could be considered later.
The rights group objected to two main elements of this proposal. One is the nine-week limit on use of the medications. The other is the decision to restrict prescribing and dispensing rights to doctors at large hospitals in the initial period.
HRW pointed out that widely accepted medical standards support medication abortion up to 12 weeks of pregnancy. It also noted that the World Health Organization recommends that a wider pool of properly trained health professionals be allowed to provide these services.
According to the group, keeping the number of authorized providers small could slow women’s access to timely care. The problem would be most acute for women who already find it difficult to reach major hospitals.
HRW also urged the National Assembly to bring abortion legislation in line with international human rights norms. The group recommended that abortion-related services be covered under the National Health Insurance scheme. It further called for clear legal safeguards protecting both patients and medical professionals.
Abortion law in South Korea has remained in limbo for years. The Constitutional Court struck down the existing restrictions in 2019, ruling that the law required revision. Yet necessary amendments have not been enacted, and the regulatory vacuum around abortion pills and related medical services has persisted.
The government maintains that placing abortion medications within a formal system is intended to safeguard women’s health and safety. It has said in the past that women should be able to receive care within a secure medical framework rather than relying on unproven methods.